IndiaPosted at: Nov 8 2024 7:02PM


Delhi HC quashes Rs 218 cr stamp duty order against Ambuja Cement

Delhi HC quashes Rs 218 cr stamp duty order against Ambuja Cement

New Delhi, Nov 8 (UNI) The Delhi High Court ruled in favour of Ambuja Cement Limited and overturned a show cause notice and an order of Collector of Stamps, Delhi that demanded ₹218.87 crores in stamp duty and Rs 69 crore as penalty.
The court quashed the stamp duty charges and penalty against Ambuja Cement.

Please log in to get detailed story.
Tags: #Delhi HC quashes Rs 218 cr stamp duty order against Ambuja Cement
More News
Delhi court adjourns hearing in defamation complaint against Nirmala Sitharaman

Delhi court adjourns hearing in defamation complaint against Nirmala Sitharaman

13 Jun 2025 | 9:11 PM

New Delhi, Jun 13 (UNI) A Delhi court adjourned hearing on Friday in a defamation complaint filed against Finance Minister Nirmala Sitharaman on the request of her counsel.

see more..
Punjab: Woman arrested for rape, conspiracy

Punjab: Woman arrested for rape, conspiracy

13 Jun 2025 | 8:38 PM

Phagwara, Jun 13 (UNI) The Nakodar sadar police in Punjab have arrested a woman on the charge of rape and criminal conspiracy.

see more..

One Nation, One Election key to strengthening Indian Democracy: Kalraj Mishra

13 Jun 2025 | 8:32 PM

New Delhi, June 13 (UNI) The implementation of One Nation, One Election will not only strengthen Indian democracy but also open new avenues for the country's development and prosperity, former Union Minister and ex Governor Kalraj Mishra said here on Friday.

see more..
DGCA issues additional safety guidelines for Air India’s Boeing 787

DGCA issues additional safety guidelines for Air India’s Boeing 787

13 Jun 2025 | 6:47 PM

New Delhi, June 13 (UNI) In the wake of air crash involving Boeing Dreamliner 787, the Directorate General of Civil Aviation (DGCA) on Friday issued guidelines to Air India for additional safety inspections and measures to be carried out before the operation and maintenance of the aircraft.

see more..
SII, DNDi in pact to develop affordable dengue treatment

SII, DNDi in pact to develop affordable dengue treatment

13 Jun 2025 | 6:05 PM

New Delhi, June 13 (UNI) The Serum Institute of India (SII), the world’s largest vaccine manufacturer and Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research entity, have entered into a partnership with an aim to accelerate the development of a monoclonal antibody treatment for dengue fever.

see more..